Technology
Impact of High Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia
2021-05-15
CHEST June 2021, Volume 159, Issue 6
Charles Tacquard, MD, joins CHEST Podcast Moderator, Gretchen Winter, MD, to discuss high dose prophylactic anticoagulation in critically ill patients with COVID-19 pneumonia.
DOI: https://doi.org/10.1016/j.chest.2021.01.017
More Episodes
Machine Learning and Prediction of All-Cause Mortality in COPD
2020-09-03
1.3k
2020-09-03
1.3k
The Strategic Establishment of PCCM as a Subspecialty in China
2020-05-05
1.1k
2020-05-05
1.1k
Preparing for the COVID-19 Pandemic: Our Experience in New York
2020-05-04
1.1k
2020-05-04
1.1k
Recent Advances in Severe Asthma Therapies
2020-03-04
912
2020-03-04
912
Diagnostic Evaluation After Lung Cancer Screening
2020-02-04
782
2020-02-04
782
Can Screening for COPD Improve Outcomes?
2020-01-14
710
2020-01-14
710
Battling Intensivist Burnout: A Role for Workload Management
2019-11-04
559
2019-11-04
559
Get this podcast on your
phone, FREE
